Related Experiment Videos
Subarachnoid sufentanil for extracorporeal shock lithotripsy
1Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, NY 14642, USA.
Regional Anesthesia
|January 1, 1997
Summary
Subarachnoid sufentanil provides safe and effective anesthesia for extracorporeal shock wave lithotripsy. This analgesic technique resulted in successful treatments and comparable discharge times to other methods.
Area of Science:
- Anesthesiology
- Urology
Background:
- Extracorporeal shock wave lithotripsy (ESWL) utilizes various anesthetic techniques.
- Each anesthetic method for ESWL presents unique advantages and limitations.
Purpose of the Study:
- To evaluate the efficacy and safety of subarachnoid sufentanil for pain management during lithotripsy.
Main Methods:
- A retrospective study analyzed 20 patients undergoing lithotripsy.
- Patients received subarachnoid sufentanil for anesthesia.
- Key assessments included need for supplemental anesthesia, adverse events, and patient discharge times.
Main Results:
- Subarachnoid sufentanil achieved successful anesthesia in 18 out of 20 patients.
- One patient experienced inadequate anesthesia, and one procedure was postponed due to pruritus.
- Four patients had adverse effects, all successfully managed. Mean discharge was 132 minutes.
Conclusions:
- Subarachnoid sufentanil is a safe and effective anesthetic option for lithotripsy.
- Further prospective research comparing subarachnoid sufentanil to alternative anesthetic techniques is warranted.